USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ossur Iceland EHF

USPTO PatentsView assignee record - 185 granted patents across 31 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ossur ranks #2,131 of 49,997 tracked US assignees by granted-patent volume, with 185 patents across 31 technology areas.

#2,131
of 49,997 US assignees by volume
Top 8%
by Innovation Score (54.5/100)
13.9
avg claims per patent
+172%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2131 · Foreign Corporation #2,131 · 185 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 185 grants
  • TOP-DECILE #2,131/49,997
  • PHOTO-FINISH Canon Anelva
  • CPC-FOCUS A61F · 31 areas
  • INNOV-PAR 54.5/100
  • CLAIMS-RICH 13.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +172% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Canon Anelva Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Ossur

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ossur's Innovation Score is 54.5/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Ossur's grants concentrate

Ossur Iceland EHF is a focused PatentsView assignee: 31 CPC subclasses with 84.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (30 grants) versus a trough of 1 in 2016. By volume, Ossur sits between Canon Anelva Corporation and Raytheon BBN Technologies Corp..

Ossur's three-year grant acceleration

From 2019–2021 to 2022–2024, Ossur Iceland EHF moved from 67 to 85 grants (1.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #683. See the growth leaderboard.

Who files at Ossur's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ossur holds 185 patents at rank #2,131, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ossur

By rank, the assignees closest to #2,131 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Ossur's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ossur, neither rank-band nor same-CPC leaders (those blocks stay above).

Ossur's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 2016201720182019202020212022202320242025 14
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Ossur Iceland EHF patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 0.5%
2017 8 4.3%
2018 10 5.4%
2019 27 14.6%
2020 20 10.8%
2021 20 10.8%
2022 30 16.2%
2023 27 14.6%
2024 28 15.1%
2025partial year 14 7.6%

Which technologies does Ossur Iceland EHF patent most?

Top 15 of 31 technology areas

Where it ranks

Overall rank by patents

#2,131

of 49,997 tracked assignees

Innovation Score

54.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Ossur Iceland EHF's patent record in context - here's where to go next.

  • Ossur Iceland EHF's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 84.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #2,131 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ossur Iceland EHF against Canon Anelva Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 54.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.